(Q37636159)

21 August 2017

1 reference

title

Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease (English)

1 reference

21 August 2017

1 reference

P Rolan

1

1 reference

21 August 2017

Mr Hutchinson

series ordinal

2

1 reference

21 August 2017

Kw Johnson

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

Expert Opinion on Pharmacotherapy

21 August 2017

published in

1 reference

21 August 2017

volume

10

1 reference

21 August 2017

issue

17

1 reference

21 August 2017

page(s)

2897-2904

1 reference

Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Preferential inhibition of human phosphodiesterase 4 by ibudilast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

The inhibitory profile of Ibudilast against the human phosphodiesterase enzyme family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Effect of ibudilast, a novel antiasthmatic agent, on anaphylactic bronchoconstriction: predominant involvement of endogenous slow reacting substance of anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Inhibitory effect of ibudilast (KC-404) on the expression of the beta2 integrin family on an eosinophilic cell line (EoL-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Cyclic GMP/cyclic GMP-dependent protein kinase system prevents excitotoxicity in an immortalized oligodendroglial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Ibudilast attenuates astrocyte apoptosis via cyclic GMP signalling pathway in an in vitro reperfusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Ibudilast suppresses TNFalpha production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Ibudilast, a phosphodiesterase inhibitor, protects against white matter damage under chronic cerebral hypoperfusion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Glial regulation of the cerebral microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Pathological and protective roles of glia in chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

The involvement of glial cells in the development of morphine tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Efficacy of Ibudilast on lower limb circulation of diabetic patients with minimally impaired baseline flow: a study using color Doppler ultrasonography and laser Doppler flowmetry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

Ibudilast, a nonselective phosphodiesterase inhibitor, regulates Th1/Th2 balance and NKT cell subset in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903426189

10.1517/14656560903426189

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference